Third-party tested · 1–3 day shippingShop the catalog
Back to catalog
TB-500 - Emetrix Research Labs branded vial

Recovery & Repair Studies

TB-500

Thymosin Beta-4 fragment — recovery & repair research.

In Stock
Lyophilized Powder
$60.00
Research-use disclaimer: For research use only. Not for human or veterinary use.

Specifications

Formula
C50H69N13O10
Molecular Weight
988.18 g/mol
Storage
Store at 2-8°C / 36-46°F
Form
Lyophilized Powder

Description

A synthetic peptide studied in research on muscle tissue, recovery, and performance biomarkers.

Compound Guide

What is TB-500?

Cell Migration & Structural Recovery

Tissue RepairFlexibilityInflammation

TB-500 is the synthetic form of the active region of Thymosin Beta-4, a naturally occurring peptide present in nearly all human cells. Its central mechanism in research is actin regulation — the cytoskeletal protein that governs cell migration, meaning repair cells can travel to damaged tissue more efficiently.

Areas of Research Interest

Summarized from published research findings. Not medical guidance or prescribing information.

Actin Upregulation

Promotes cell migration toward injury sites, the mechanistic basis for most TB-500 research.

Vascularization

Studied for new capillary formation in poorly perfused connective tissue.

Flexibility Endpoints

Range-of-motion and scar-tissue measures are common in TB-500 protocols.

Inflammatory Modulation

Examined for downregulation of inflammatory signaling in repair models.

Systemic Distribution

Low molecular weight allows broad tissue distribution rather than local-only action.

Long Dosing Interval

Extended half-life permits twice-weekly rather than daily administration in most designs.

Reconstitution

  • 5 mg vial + 2 mL bacteriostatic water = 2.5 mg/mL
  • 10 mg vial + 5 mL bacteriostatic water = 2.0 mg/mL
  • At 2.5 mg/mL, 40 units on a U-100 syringe = 1 mg
Open the peptide calculator

Suggested research protocol

  • Route studied: subcutaneous, site rotation recommended.
  • Loading phase: higher twice-weekly dosing for 4–6 weeks.
  • Maintenance phase: reduced weekly dosing thereafter.
  • Refrigerate reconstituted vials; use within 30 days.

Dosing Reference

PhaseAmountFrequency
Loading (wk 1–6)2–2.5 mgTwice weekly
Maintenance2 mgOnce weekly
Taper1 mgEvery 10–14 days

Handling & Notes

  • Effects in the literature accumulate over weeks rather than days — short blocks are uninformative.
  • Frequently studied alongside BPC-157 rather than in isolation.
  • Do not freeze reconstituted solution.

This guide is provided for informational and research reference only. TB-500 is intended for laboratory research use exclusively and is not intended to diagnose, treat, cure, or prevent any disease. Not for human or veterinary consumption.